Preferred Label : Autologous CD34-positive BCL11A-disrupted Hematopoietic Progenitor Cells BIVV003;
NCIt synonyms : Autologous CD34 Hematopoietic Stem Cells BIVV003; HSPCs BIVV003; Autologous CD34-positive BCL11A-disrupted HPCs BIVV003;
NCIt definition : A population of autologous cluster of differentiation 34 (CD34)-positive hematopoietic
progenitor cells (HPCs) that are transfected ex vivo with zinc finger nuclease (ZFN)
messenger ribonucleic acid (mRNA) targeting the B-cell lymphoma/leukemia 11A (BCL11A)
locus, with potential usage for transplantation in patients with sickle cell disease
(SCD). CD34-positive HPCs are isolated from human blood upon apheresis and are genetically
modified in vitro using ZFN technology to specifically cleave and disrupt the erythroid
enhancer of the BCL11A gene. This suppresses the production of sickle hemoglobin.
Upon infusion into the patient following conditioning chemotherapy, the autologous
CD34-positive BCL11A-disrupted HPCs BIVV003 can populate the bone marrow and differentiate
into a variety of blood cell types including lymphoid cells, myeloid cells and erythroblasts.
As BCL11A is a suppressor of fetal hemoglobin (HbF) expression, disruption of the
BCL11A enhancer decreases the expression of BCL11A and stimulates the expression of
HbF in erythrocytes that differentiate from BIVV003. HbF may compensate for reduced
or absent expression of adult hemoglobin in patients with SCD.;
Molecule name : BIVV003;
NCI Metathesaurus CUI : CL936984;
Origin ID : C157393;
UMLS CUI : C4763592;
Semantic type(s)
- Cell [UMLS semantic type]
- concept_is_in_subset
